361 related articles for article (PubMed ID: 31557990)
1. Autoantibodies in Neuropsychiatric Disorders.
Hoffmann C; Zong S; Mané-Damas M; Molenaar P; Losen M; Martinez-Martinez P
Antibodies (Basel); 2016 Apr; 5(2):. PubMed ID: 31557990
[TBL] [Abstract][Full Text] [Related]
2. Psychiatric Autoimmunity: N-Methyl-D-Aspartate Receptor IgG and Beyond.
Kruse JL; Lapid MI; Lennon VA; Klein CJ; Toole OO; Pittock SJ; Strand EA; Frye MA; McKeon A
Psychosomatics; 2015; 56(3):227-41. PubMed ID: 25975857
[TBL] [Abstract][Full Text] [Related]
3. Frequency of Synaptic Autoantibody Accompaniments and Neurological Manifestations of Thymoma.
Zekeridou A; McKeon A; Lennon VA
JAMA Neurol; 2016 Jul; 73(7):853-9. PubMed ID: 27135398
[TBL] [Abstract][Full Text] [Related]
4. Neuronal central nervous system syndromes probably mediated by autoantibodies.
Chefdeville A; Honnorat J; Hampe CS; Desestret V
Eur J Neurosci; 2016 Jun; 43(12):1535-52. PubMed ID: 26918657
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of serum anti-neuronal autoantibodies in patients admitted to acute psychiatric care.
Schou M; Sæther SG; Borowski K; Teegen B; Kondziella D; Stoecker W; Vaaler A; Reitan SK
Psychol Med; 2016 Dec; 46(16):3303-3313. PubMed ID: 27609625
[TBL] [Abstract][Full Text] [Related]
6. Autoantibodies in patients with obsessive-compulsive disorder: a systematic review.
Denzel D; Runge K; Feige B; Pankratz B; Pitsch K; Schlump A; Nickel K; Voderholzer U; Tebartz van Elst L; Domschke K; Schiele MA; Endres D
Transl Psychiatry; 2023 Jul; 13(1):241. PubMed ID: 37400462
[TBL] [Abstract][Full Text] [Related]
7. [Update on anti-NMDA receptor encephalitis].
Iizuka T; Sakai F; Mochizuki H
Brain Nerve; 2010 Apr; 62(4):331-8. PubMed ID: 20420172
[TBL] [Abstract][Full Text] [Related]
8. Neuronal Surface Autoantibodies in Neuropsychiatric Disorders: Are There Implications for Depression?
Zong S; Hoffmann C; Mané-Damas M; Molenaar P; Losen M; Martinez-Martinez P
Front Immunol; 2017; 8():752. PubMed ID: 28725222
[TBL] [Abstract][Full Text] [Related]
9. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG
Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482
[TBL] [Abstract][Full Text] [Related]
10. Autoantibodies and epilepsy.
Bien CG; Scheffer IE
Epilepsia; 2011 May; 52 Suppl 3():18-22. PubMed ID: 21542841
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of N-methyl-D-aspartate glutamate receptor (NMDA-R) autoantibodies in aging subjects without neuropsychiatric disorders and in dementia patients.
Busse S; Busse M; Brix B; Probst C; Genz A; Bogerts B; Stoecker W; Steiner J
Eur Arch Psychiatry Clin Neurosci; 2014 Sep; 264(6):545-50. PubMed ID: 24604707
[TBL] [Abstract][Full Text] [Related]
12. Anti-neuronal anti-bodies in patients with early psychosis.
Mantere O; Saarela M; Kieseppä T; Raij T; Mäntylä T; Lindgren M; Rikandi E; Stoecker W; Teegen B; Suvisaari J
Schizophr Res; 2018 Feb; 192():404-407. PubMed ID: 28461116
[TBL] [Abstract][Full Text] [Related]
13. Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy.
Wright S; Geerts AT; Jol-van der Zijde CM; Jacobson L; Lang B; Waters P; van Tol MJ; Stroink H; Neuteboom RF; Brouwer OF; Vincent A
Epilepsia; 2016 May; 57(5):823-31. PubMed ID: 26996997
[TBL] [Abstract][Full Text] [Related]
14. Autoantibodies to neurotransmitter receptors and ion channels: from neuromuscular to neuropsychiatric disorders.
Martinez-Martinez P; Molenaar PC; Losen M; Stevens J; Baets MH; Szoke A; Honnorat J; Tamouza R; Leboyer M; Os JV; Rutten BP
Front Genet; 2013 Sep; 4():181. PubMed ID: 24065983
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to surface dopamine-2 receptor in autoimmune movement and psychiatric disorders.
Dale RC; Merheb V; Pillai S; Wang D; Cantrill L; Murphy TK; Ben-Pazi H; Varadkar S; Aumann TD; Horne MK; Church AJ; Fath T; Brilot F
Brain; 2012 Nov; 135(Pt 11):3453-68. PubMed ID: 23065479
[TBL] [Abstract][Full Text] [Related]
16. A Study of Autoantibodies against Some Central Nervous System Antigens and the IL-35 Serum Level in Schizophrenia.
Soltani M; Beshkar P; Mokhtarian K; Anjomshoa M; Mohammad-Rezaei M; Azadegan-Dehkordi F; Mirzaei Y; Majidi J; Bagheri N
Iran J Allergy Asthma Immunol; 2022 Aug; 21(4):441-448. PubMed ID: 36243932
[TBL] [Abstract][Full Text] [Related]
17. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis.
Steiner J; Walter M; Glanz W; Sarnyai Z; Bernstein HG; Vielhaber S; Kästner A; Skalej M; Jordan W; Schiltz K; Klingbeil C; Wandinger KP; Bogerts B; Stoecker W
JAMA Psychiatry; 2013 Mar; 70(3):271-8. PubMed ID: 23344076
[TBL] [Abstract][Full Text] [Related]
18. Investigation of neuronal auto-antibodies in systemic lupus erythematosus patients with epilepsy.
Karaaslan Z; Ekizoğlu E; Tektürk P; Erdağ E; Tüzün E; Bebek N; Gürses C; Baykan B
Epilepsy Res; 2017 Jan; 129():132-137. PubMed ID: 28043063
[TBL] [Abstract][Full Text] [Related]
19. Autoantibodies to central nervous system neuronal surface antigens: psychiatric symptoms and psychopharmacological implications.
Pollak TA; Beck K; Irani SR; Howes OD; David AS; McGuire PK
Psychopharmacology (Berl); 2016 May; 233(9):1605-21. PubMed ID: 26667479
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
